A multi‐analyte cell‐free <scp>DNA</scp> –based blood test for early detection of hepatocellular carcinoma

医学 肝细胞癌 内科学 接收机工作特性 置信区间 阶段(地层学) 胃肠病学 血液检验 指南 前瞻性队列研究 肿瘤科
作者
Nan Lin,Yongping Lin,Jian Ming Xu,Dan Liu,Diange Li,Hongyu Meng,Maxime A. Gallant,Naoto Kubota,Dhruvajyoti Roy,Junhong Li,Emmanuel C. Gorospe,Morris Sherman,Robert G. Gish,Ghassan K. Abou‐Alfa,Joseph K. Lim,David J. Taggart,Richard A. Van Etten,Yujin Hoshida,Wenqian Li
出处
期刊:Hepatology communications [Lippincott Williams & Wilkins]
标识
DOI:10.1002/hep4.1918
摘要

The limited performance of guideline-recommended abdominal ultrasound and serum alpha-fetoprotein (AFP) highlights the urgent, unmet need for new biomarkers for more accurate detection of early hepatocellular carcinoma (HCC). To this end, we have conducted a prospective clinical validation study to evaluate the performance of the HelioLiver Test, a multi-analyte blood test combining cell-free DNA methylation patterns, clinical variables, and protein tumor markers. A blinded, multicenter validation study was performed with 247 subjects, including 122 subjects with HCC and 125 control subjects with chronic liver disease. The performance of the HelioLiver Test was compared with AFP and the GALAD score as established HCC surveillance blood tests. The performance of the HelioLiver Test (area under the receiver operating characteristic curve [AUROC] = 0.944) was superior to both AFP (AUROC = 0.851; p < 0.0001) and GALAD (AUROC = 0.899; p < 0.0001). Using a prespecified diagnostic algorithm, the HelioLiver Test showed sensitivities of 85% (95% confidence interval [CI], 78%-90%) for HCC of any stage and 76% (95% CI, 60%-87%) for early stage (American Joint Committee on Cancer [AJCC] I and II) HCC. In contrast, AFP (≥20 ng/mL) alone and the GALAD score (≥-0.63) showed lower sensitivities of 62% (95% CI, 54%-70%) and 75% (95% CI, 67%-82%) for HCC overall, and 57% (95% CI, 40%-71%) and 65% (95% CI, 49%-79%) for early stage (AJCC I and II) HCC, respectively. The specificities of the HelioLiver Test (91%; 95% CI, 85%-95%), AFP (97%; 95% CI, 92%-99%), and the GALAD score (94%; 95% CI, 88%-97%) were similar for control subjects. The HelioLiver Test showed superior performance for HCC detection compared to with both AFP and the GALAD score and warrants further evaluation in HCC surveillance settings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
iitj驳回了所所的应助
1秒前
何曼慈发布了新的文献求助10
1秒前
别让乌云遮住你的阳光完成签到,获得积分20
1秒前
1秒前
Xing发布了新的文献求助10
1秒前
顺利毕业发布了新的文献求助10
2秒前
技术的不能发表完成签到,获得积分10
2秒前
2秒前
西贝发布了新的文献求助10
2秒前
拼搏翠安发布了新的文献求助30
3秒前
欢呼的安白完成签到,获得积分10
3秒前
arpege完成签到,获得积分10
3秒前
3秒前
jj发布了新的文献求助10
3秒前
一页墨城完成签到,获得积分10
4秒前
4秒前
文静的念露完成签到,获得积分10
4秒前
4秒前
4秒前
lemon发布了新的文献求助20
4秒前
寂寞的小鱼的应助被yurig采纳,获得10
6秒前
6秒前
6秒前
发nature完成签到 ,获得积分10
6秒前
研友_LwlNdn的应助被123采纳,获得10
6秒前
7秒前
我是老大的应助被han采纳,获得10
7秒前
简单生活发布了新的文献求助10
7秒前
123qwe发布了新的文献求助10
8秒前
酷波er的应助被三石采纳,获得10
8秒前
z33发布了新的文献求助10
8秒前
9秒前
酷波er的应助被面条大王采纳,获得10
10秒前
Happyocean完成签到,获得积分10
10秒前
在水一方的应助被简隋英采纳,获得10
10秒前
852的应助被stone采纳,获得10
11秒前
11秒前
神宝嘎li发布了新的文献求助10
11秒前
11秒前
biancaliu发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124